NYSE: NSRX

Nasus Pharma Ltd

CIK 0002029039 · SIC 2834 · Pharmaceutical Preparations

Mid by revenue · Micro by assets Revenue $1.2B Assets $5M as of Sep 20, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (LAC 10-Q) is open in full — no account needed.

424B5 Filed Sep 18, 2026 Red flag

Nasus Pharma files for up to $8.5M at-the-market offering of Ordinary Shares

5 material changes detected. Sign up free to read the summary.

View report
424B4 Filed Aug 14, 2025

Summary not yet generated.

Partner

Trade NSRX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View all filings for NSRX on SEC EDGAR